ASCO 2022 Conference Coverage
D

ASCO 2022 on Randomized Phase II Trial of Neoadjuvant ADT + Abiraterone & Apalutamide for High-Risk Localized Prostate Cancer: Pathologic Response and PSMA Imaging Correlates

By ASCO 2022 Conference Coverage FEATURING Diogo Bastos
By ASCO 2022 Conference Coverage FEATURING Diogo Bastos
244 views
June 9, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

20:25
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

21:17
Janssen Oncology

The Man Cave

Feat. J. Hamilton, M. Fabrizio, M. Taha

Related Content

AUTOPLAY
47:11
Houston Methodist Hospital

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis
16:05
Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini
27:04
Fengting Yan

Cancer Screening Molecular Tools

05:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare …

Feat. S. Tagawa
08:05
Total Health

Prostate Cancer Updates From ASCO® 2023

Feat. T. Zhang
11:39
Oncology Data Advisor

Recent Prostate Cancer Updates

Feat. U. Vaishampayan
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
19:07
Stanford Medicine

Stanford Medicine Advances in Imaging to Improve Prostate Cancer Dia…

Feat. G. Sonn
25:33
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute Prostate Cancer Updates From ASCO GU 20…

Feat. J. Berchuck, A. Choudhury
14:51
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Tailoring Prostate Cancer Care - EMBARK…

Feat. S. Freedland
10:12
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Phase 3 Randomized EMBARK Study - Enzaluta…

Feat. S. Freedland
42:54
Houston Methodist Hospital

30 Years Perspective on Advanced Prostate Cancer: Using Biology &…

Feat. M. Hussain
11:27
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "EMBARK Trial - Outcomes of Men With Hi…

Feat. N. Shore
17:23
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PSMA-PET Imaging Case Studies and Sequenc…

Feat. P. Tran
09:02
Cedars Sinai

Year in Review: EMBARK Study and the Evolving Role of Intensified AD…

Feat. S. Freedland
51:15
Masonic Cancer Center, University of Minnesota

Cooked Meat and Prostate Cancer

Feat. R. Turesky
10:40
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Systemic Treatment of High-Risk Biochem…

Feat. C. Paller
04:48
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "EMBARK Secondary Endpoints - Enzalutamide …

Feat. U. De Giorgi
17:43
ecancer

ASCO® GU 2024 Panel Discussion: "Latest in PARPi for Prostate C…

Feat. F. Schlürmann, N. Adra, E. Antonarakis, H. Kitamura
11:35
PROSCA & BLADDR 2023

Nodal Recurrences in Prostate Cancer: What Is the Optimal Approach?

Feat. P. Ost